Optimize Cardiovascular Devices Through Simulation
With more than 30 percent of all deaths attributed to cardiovascular diseases, the healthcare industry invests massively in disease prevention, treatment, and efforts to shorten the recovery period. The extensive in vitro and in vivo testing required to ensure patient safety inevitably slows the delivery of innovative implantable cardiovascular devices — stents, valves, or pacemakers/defibrillators — to those who need them the most. Leveraging the power of in silico medicine and developing a detailed and reliable multiphysics model of the device and its working environment (the human body) provides the necessary insights to test and optimize new products, help accelerate regulatory approval, and save lives.